Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
42
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Incyte
AN
AnalystConsensusTarget
Consensus Narrative from 23 Analysts
Pipeline And Precision Medicine Will Transform Global Immunotherapy Landscape
Key Takeaways Launches of new therapies and strong international uptake support diversified revenue growth and decreased geographic risk, especially in immunology and oncology markets. Focused investment in late-stage assets, precision medicine partnerships, and operating expense control enhance margin prospects and resilience against competitive pressures.
View narrative
US$80.83
FV
7.5% overvalued
intrinsic discount
8.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
38
users have followed this narrative
3 days ago
author updated this narrative
Block
AN
AnalystConsensusTarget
Consensus Narrative from 37 Analysts
Cash App And Square Expansion Will Drive Fintech Amid Risks
Key Takeaways Accelerated product launches, embedded banking, and cryptocurrency integration are driving user growth, deeper engagement, and expansion into higher-margin revenue streams. Innovation in business tools and aggressive international and upmarket expansion boost Block's relevance and market share, supporting long-term revenue and margin growth.
View narrative
US$86.88
FV
12.8% undervalued
intrinsic discount
11.23%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
154
users have followed this narrative
1 day ago
author updated this narrative
TTM Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
New Data Centers And Manufacturing Sites Will Secure Lasting Demand
Key Takeaways Demand for advanced PCBs from AI, cloud, and defense markets, plus domestic sourcing trends, strengthens TTM's growth, customer ties, and revenue stability. Expansion into engineered solutions, automation, and disciplined operations enhances pricing power, margins, and cash flow resilience.
View narrative
US$56.75
FV
26.3% undervalued
intrinsic discount
6.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
Cardlytics
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Content Restrictions And Concentration Will Curb Performance But Spark Progress
Key Takeaways Heavy reliance on a few major bank partners creates significant vulnerability to revenue loss and partner-specific disruptions. New partnerships and innovations are slow to offset recent setbacks, while stricter data rules and underinvestment threaten future growth and profitability.
View narrative
US$1.50
FV
19.3% undervalued
intrinsic discount
-13.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
SoundThinking
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Municipal Delays And Regulatory Hurdles Will Underpin Cautious Optimism
Key Takeaways Exposure to municipal budget cycles, contract concentration, and procurement delays adds volatility to revenue and increases risk of abrupt financial disruptions. Regulatory, political, and competitive pressures could restrict adoption, limit market share expansion, and constrain long-term earnings growth.
View narrative
US$19.00
FV
32.8% undervalued
intrinsic discount
7.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Biodesix
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Lung Diagnostics Will Face Regulatory Delays While Modest Progress Unfolds
Key Takeaways Operational and reimbursement hurdles may restrict revenue growth and margin expansion despite efforts to widen adoption and capitalize on innovative diagnostic trends. Competitive threats and shifting technology demands require sustained investment, raising compliance and R&D costs while heightening risks to long-term profitability.
View narrative
US$1.50
FV
73.6% undervalued
intrinsic discount
18.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Clarus
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Digital Shifts And Pricing Wars Will Compress Margins
Key Takeaways Shifting consumer preferences and adverse weather trends challenge Clarus' core market, risking stagnant sales and reduced demand for its key outdoor brands. Intensifying price competition, regulatory costs, and niche brand dependence threaten margins and long-term earnings, increasing risks of underperformance and weak cash flow.
View narrative
US$3.00
FV
13.0% overvalued
intrinsic discount
4.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ADC Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Regulatory And Pipeline Risks Will Stunt Progress But Hope Remains
Key Takeaways Heavy reliance on a single drug exposes the company to revenue volatility and risks from competitive and regulatory developments. High costs and intense competition from emerging therapies may constrain profitability and limit future market share.
View narrative
US$5.00
FV
37.4% undervalued
intrinsic discount
24.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Jadestone Energy
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Operational Delays In Asia Will Constrain Output But Spur Recovery
Key Takeaways Delays in key projects and reliance on mature, outage-prone assets threaten near-term production growth and could undermine margin improvements. Rising decommissioning costs, regulatory pressures, and shifting market dynamics toward renewables limit long-term growth potential and may erode future profitability.
View narrative
UK£0.50
FV
60.8% undervalued
intrinsic discount
10.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies